Radioiodine remnant ablation of differentiated thyroid cancer does not further increase oxidative damage to membrane lipids - early effect
<p>Abstract</p> <p>Introduction</p> <p>Radioiodine (<sup>131</sup>I) therapy is widely accepted as an essential part of therapeutic regimens in many cases of differentiated thyroid cancer. Radiation-induced oxidative damage to macromolecules is a well known...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2010-10-01
|
| Series: | Thyroid Research |
| Online Access: | http://www.thyroidresearchjournal.com/content/3/1/7 |